Public investments in biomedical research have an outsized effect, driving new scientific insights, economic growth, and ultimately treatments and cures.
Image: Ten Image/Science Photo Library via Getty Images
Genetic testing beneficial in critically ill adults
Penn Medicine researchers have identified genetic conditions in a large percent of adults admitted to the intensive care unit, dispelling the belief that genetic testing only benefits a pediatric population.
The actual chip of human leukemia bone marrow where chambers and channels were filled with food dyes.
(Image: NYU Tandon Applied Micro-Bioengineering Laboratory/Courtesy of Weiqiang Chen)
‘Leukemia-on-a-chip’ could transform CAR T blood cancer treatments
In a collaborative effort with NYU, Penn researchers have helped pioneer a novel 3D platform that mimics the human bone marrow and immune environment, enabling more predictive testing of cancer immunotherapy success in patients, including CAR T cell therapies.
Timethius Terrell serves as program lead for Red Ribbon Connect. He’s dedicated to promoting global collaboration in HIV/AIDS research.
(Image: Elliot Sipila)
Red Ribbon Connect links Penn with HIV/AIDS researchers worldwide
Organized by a recent Penn alum on the Community Advisory Board of the Penn Center for AIDS Research, the newly launched Red Ribbon Connect program entails a monthly virtual exchange for HIV/AIDS researchers at Penn and worldwide to swap insights and perspectives.
Food insecurity linked to elevated mortality risk among cancer survivors
A new study from the Perelman School of Medicine shows that cancer survivors experiencing food insecurity had a 28 percent relative increase in risk of death versus those who were food secure.
Gene therapy may slow loss of motor function in ALS
Researchers at the Perelman School of Medicine and Children's Hospital of Philadelphia used RNA interference to silence a key protein that causes ALS, showing promise for treating the devastating neurodegenerative disease.
Innovative program jointly launched by Independence Blue Cross and Penn Medicine accelerates access to outpatient scans
A joint program from Independence Blue Cross (IBX) and Penn Medicine gets patients on the path to care and a diagnosis faster and to save both providers and IBX time on prior authorization requests for outpatient scans (such as, CT, PET, and nuclear medicine scans, MRI and echocardiograms). Launched in 2023, the success of the program has driven IBX to expand the program to other network providers.
Nancy A. Speck honored for pioneering research in hematology
Speck, the John W. Eckman Professor in Medical Science II and chair of the department of Cell and Developmental Biology in the Perelman School of Medicine, has been named the 2025 recipient of the E. Donnall Thomas Lecture and Prize from the American Society of Hematology.
